» Articles » PMID: 35678862

Association Between Visual Emphysema and Lung Nodules on Low-dose CT Scan in a Chinese Lung Cancer Screening Program (Nelcin-B3)

Abstract

Objectives: This study aimed to evaluate the association between visual emphysema and the presence of lung nodules, and Lung-RADS category with low-dose CT (LDCT).

Methods: Baseline LDCT scans of 1162 participants from a lung cancer screening study (Nelcin-B3) performed in a Chinese general population were included. The presence, subtypes, and severity of emphysema (at least trace) were visually assessed by one radiologist. The presence, size, and classification of non-calcified lung nodules (≥ 30 mm) and Lung-RADS category were independently assessed by another two radiologists. Multivariable logistic regression and stratified analyses were performed to estimate the association between emphysema and lung nodules, Lung-RADS category, after adjusting for age, sex, BMI, smoking status, pack-years, and passive smoking.

Results: Emphysema and lung nodules were observed in 674 (58.0%) and 424 (36.5%) participants, respectively. Participants with emphysema had a 71% increased risk of having lung nodules (adjusted odds ratios, aOR: 1.71, 95% CI: 1.26-2.31) and 70% increased risk of positive Lung-RADS category (aOR: 1.70, 95% CI: 1.09-2.66) than those without emphysema. Participants with paraseptal emphysema (n = 47, 4.0%) were at a higher risk for lung nodules than those with centrilobular emphysema (CLE) (aOR: 2.43, 95% CI: 1.32-4.50 and aOR: 1.60, 95% CI: 1.23-2.09, respectively). Only CLE was associated with positive Lung-RADS category (p = 0.02). CLE severity was related to a higher risk of lung nodules (ranges aOR: 1.44-2.61, overall p < 0.01).

Conclusion: In a Chinese general population, visual emphysema based on LDCT is independently related to the presence of lung nodules (≥ 30 mm) and specifically CLE subtype is related to positive Lung-RADS category. The risk of lung nodules increases with CLE severity.

Key Points: • Participants with emphysema had an increased risk of having lung nodules, especially smokers. • Participants with PSE were at a higher risk for lung nodules than those with CLE, but nodules in participants with CLE had a higher risk of positive Lung-RADS category. • The risk of lung nodules increases with CLE severity.

Citing Articles

Co-occurrence of bronchiectasis, airway wall thickening, and emphysema in Chinese low-dose CT screening.

Nie Z, Vonder M, de Vries M, Yang X, Oudkerk M, Slebos D Eur Radiol. 2025; .

PMID: 39775898 DOI: 10.1007/s00330-024-11231-3.


Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.

Hu K, Gao L, Zhang R, Lu M, Zhou D, Xie S Heliyon. 2024; 10(9):e30576.

PMID: 38765082 PMC: 11098830. DOI: 10.1016/j.heliyon.2024.e30576.


Effect of emphysema on AI software and human reader performance in lung nodule detection from low-dose chest CT.

Sourlos N, Pelgrim G, Wisselink H, Yang X, de Jonge G, Rook M Eur Radiol Exp. 2024; 8(1):63.

PMID: 38764066 PMC: 11102890. DOI: 10.1186/s41747-024-00459-9.


Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.

Zhang Y, Xiao L, LYu L, Zhang L PeerJ. 2024; 12:e17098.

PMID: 38495760 PMC: 10944632. DOI: 10.7717/peerj.17098.

References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Zheng R, Zeng H, Zuo T, Zhang S, Qiao Y, Zhou Q . Lung cancer incidence and mortality in China, 2011. Thorac Cancer. 2016; 7(1):94-9. PMC: 4718125. DOI: 10.1111/1759-7714.12286. View

3.
Cao M, Chen W . Epidemiology of lung cancer in China. Thorac Cancer. 2018; 10(1):3-7. PMC: 6312841. DOI: 10.1111/1759-7714.12916. View

4.
de Koning H, van der Aalst C, de Jong P, Scholten E, Nackaerts K, Heuvelmans M . Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020; 382(6):503-513. DOI: 10.1056/NEJMoa1911793. View

5.
Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G . Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017; 356:j347. PMC: 5421449. DOI: 10.1136/bmj.j347. View